Eli Lilly 2012 Annual Report Download - page 130

Download and view the complete annual report

Please find page 130 of the 2012 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

26
The committee determined the following:
Program elements. The 2012 program consisted of base salary, a cash incentive bonus, and two forms of
performance-based equity grants: PAs and SVAs. Executives also received the company employee benefits
package. This total compensation program balances the mix of cash and equity compensation, the mix of
current and longer-term compensation, the mix of internally and externally focused goals, and the security of
foundational benefits in a way that furthers the compensation objectives discussed above.
Targets. The company generally maintained pay ranges and a balance of pay elements similar to 2011. The
committee believes this overall program continues to provide cost-effective delivery of total compensation that:
encourages employee retention and engagement by delivering competitive cash and equity components
maintains a strong link to company performance and shareholder returns through a balanced equity
incentive program without encouraging excessive risk-taking
—maintains appropriate internal pay relativity
provides opportunity for total pay within the broad middle range of expected peer-group pay when company
performance is comparable to that of our peers.
The graph below shows the balance of fixed and performance-based target compensation determined by the
committee and actual compensation received for 2012 bonus. The target compensation reflects decisions made
by the compensation committee for 2012. This includes the 2012-2013 PA and the 2012-2014 SVA. Actual
compensation includes base salary and cash incentive bonus earned in 2012 and the equity awards that
completed their performance periods in 2012, namely, the 2011-2012 PA and the 2010-2012 SVA.
2012 Target and Actual Compensation (millions)
Fixed Performance based One-time
Base salary Bonus PA SVA RSU upon Hire
Cash Long-term equity
Actual base salary and bonus amounts are shown in the “Summary Compensation Table.” The PA payout for
2011-2012 performance period paid out at 50 percent of target, as shown in the “Outstanding Equity Awards at
December 31, 2012” table. The SVA payout for 2010-2012 performance was 140 percent of target, as shown in the
“Options Exercised and Stock Vested in 2012” table. Additionally, the graph above includes the vesting of a
portion of restricted stock units (RSUs) that Dr. Lundberg received upon joining the company.